Somewhere in the long human habit of seeking reassurance through the body's hidden interior, a confident voice on a popular podcast told listeners that an annual pelvic ultrasound keeps women alive. Dr. Jen Gunter, a gynecologist who has spent her career translating medicine for the public, took up the claim not to dismiss the anxiety behind it but to ask what kind of evidence could ever justify it. Her answer, drawn from some of the largest trials women's health has ever run, is that the hope of finding disease early is not the same as the proof that finding it early saves a life. The wish to
Does an Annual Pelvic Ultrasound Save Women's Lives? The Evidence Says No for Asymptomatic Women
If annual screening ultrasounds saved lives, that would be in the guidelines.
Why did this podcast clip land so hard?
Because it names a test women aren't getting and ties it to dying. Gunter says women wrote asking if they were risking their lives and why their gynecologists hadn't ordered it.
Worth noting the claim rests on one practice's experience. Do we know anything about her patients' outcomes?
No. Gunter says there's no demographic or baseline health information, and the practice doesn't take insurance, so representativeness is unknown.
What do the big trials say?
UKCTOCS, with 202,638 women, and PLCO, with 78,216, both found no drop in ovarian cancer deaths from screening.
And the earlier-stage argument? That's what the oncologist anecdote implies.
In UKCTOCS the ultrasound-only arm didn't shift stage at all. The combined arm did, but deaths didn't change.
What are the harms?
About 10 unnecessary surgeries per cancer found in UKCTOCS, and roughly 15% serious complications after false-positive surgery in PLCO.
Those are trial figures in women aged roughly 50 to 74. The source doesn't say how they'd translate to younger women.
Fair. And Gunter stresses symptoms like pain, bloating or postmenopausal bleeding still deserve prompt diagnostic imaging.
Does the race point change anything?
It shows a thin lining can falsely reassure Black women who bleed, but there's no data for those without symptoms. That's an unknown, not a finding.
Il Polso
- A viral podcast clip claiming every woman should get an annual pelvic ultrasound is spreading fear through social feeds, and women are asking why their own doctors never ordered one.
- Dr. Jen Gunter pits a single clinic's confident testimony against the large randomized trials that test whether screening actually lowers death rates.
- The UKCTOCS and PLCO trials, involving over 280,000 women combined, found no drop in ovarian cancer deaths, while false alarms led to unnecessary surgery with serious complications in about 15% of those operated on.
- Gunter steers women toward a different path: any pain, bloating, or bleeding after menopause should prompt a prompt diagnostic evaluation rather than routine scanning.
- The verdict is settling firmly: routine screening for average-risk women without symptoms is not recommended, and the guidelines remain unmoved by the viral claim.
Somewhere in the long human habit of seeking reassurance through the body's hidden interior, a confident voice on a popular podcast told listeners that an annual pelvic ultrasound keeps women alive. Dr. Jen Gunter, a gynecologist who has spent her career translating medicine for the public, took up the claim not to dismiss the anxiety behind it but to ask what kind of evidence could ever justify it. Her answer, drawn from some of the largest trials women's health has ever run, is that the hope of finding disease early is not the same as the proof that finding it early saves a life. The wish to be protected is deeply human, and the harder truth is that protection must be measured, not merely believed.
A clip from Mel Robbins' podcast has been circulating through women's social feeds, sometimes several times a day. In it, her guest Dr. Thais Aliabadi says she would make pelvic ultrasounds mandatory for every woman on the planet, adding, "That's why my patients don't die." Women wrote to Dr. Jen Gunter frightened that skipping an annual scan might cost them their lives, and asked why their own gynecologists had never ordered one.
Gunter set out to test the claim against evidence. Proving that a test saves lives requires two similar groups, one screened and one receiving standard care, followed for years. A single practice cannot provide that. Patients drift away, cases are selected, and cause and effect stay hidden. Even her own interview with gynecologist Dr. Mathew Leonardi revealed the gap: he would insist his own mother be scanned if annual scans saved lives, yet he does not recommend them for women without symptoms.
The strongest evidence comes from large trials. The UK's UKCTOCS study randomized over 200,000 women and found no reduction in ovarian or tubal cancer deaths, and for every cancer found by ultrasound, about ten women had unnecessary surgery. The American PLCO trial, enrolling nearly 78,000 women aged 55 to 74, found the same: no fewer deaths, and serious complications in about 15% of those who underwent surgery after a false alarm.
The picture is no kinder for endometrial cancer. Bleeding after menopause is the key warning sign, and catching tumors before symptoms has not improved survival. Ultrasound also misses some cancers in women without bleeding, and Black women, who face higher rates of aggressive subtypes and are less often diagnosed early, may be falsely reassured by a thin lining.
Gunter's conclusion is simple. If annual screening ultrasounds saved lives, they would appear in the guidelines. What matters is responding promptly to symptoms, especially postmenopausal bleeding, and having those symptoms taken seriously.
A clip from Mel Robbins' podcast has been landing in women's social feeds, sometimes several times a day. In it, her guest, Dr. Thais Aliabadi, says she would make it mandatory for every woman on the planet to get a pelvic ultrasound, and adds, "That's why my patients don't die." Women wrote to Dr. Jen Gunter afraid they were risking their lives by skipping an annual scan, and asking why their gynecologists had never ordered one.
Gunter, a gynecologist who writes the Vajenda newsletter, set out to test the claim against the evidence. Showing that a test lowers deaths requires two similar groups, one screened and one receiving standard care, followed for years. A single practice cannot supply that. Doctors lose track of patients who move or seek care elsewhere, and a retrospective look at one practice captures only a select slice of people and cannot establish cause and effect. Neighborhood and income also shape access to care, cancer stage at diagnosis and survival. Aliabadi's website says she does not accept insurance, calls her care "much more expensive," and describes her as the official gynecologist for many royal families and celebrities. Without data on her patients' demographics and baseline health, Gunter writes, there is no way to know how representative they are.
Gunter also interviewed Dr. Mathew Leonardi, a gynecologist, endometriosis expert and authority on gynecologic ultrasound. He told her that if annual scans saved lives he would insist his own mother have one, and since he runs an ultrasound clinic it would be easy to arrange. He does not recommend it for her, because in women without symptoms it is not helpful. The roughly 24-minute interview closes her post.
Some women told Gunter that an ultrasound at the annual exam is standard in Europe. She did not survey the continent, but checked Germany. Its IGeL-Monitor, which evaluates self-pay medical services, rates ultrasound for early detection of ovarian cancer as "negative," meaning it does not recommend it. A test being commonly sold, she notes, does not show that it is recommended or that it saves lives.
On ovarian cancer, Aliabadi recounted an oncologist telling her she was the only person he knew who sent him stage one and two cases, which she attributed to scanning every patient. Gunter points out that this is one of the best-studied questions in women's health. The UKCTOCS trial randomized 202,638 women in the UK to annual CA-125 blood testing with ultrasound triage, annual ultrasound, or no screening. Long-term follow-up showed no reduction in deaths from ovarian or tubal cancer in either screening arm. The ultrasound-only arm did not even move diagnoses to an earlier stage. The blood test plus ultrasound arm did shift diagnoses earlier, but deaths did not fall. For every ovarian or tubal cancer found by ultrasound screening, about 10 other women had unnecessary surgery after false positives.
The PLCO trial enrolled 78,216 women aged 55 to 74. They were offered annual transvaginal ultrasound and CA-125 testing for four years, then CA-125 alone for two more. Ovarian cancer deaths did not fall. Among women who had surgery after a false-positive result, about 15% suffered a serious complication. Routine ultrasound screening is not recommended for average-risk women without symptoms, though women with pain or bloating warrant a diagnostic ultrasound.
For endometrial cancer, the key signal is bleeding after menopause, present in about 90% of cases. In one study, five-year survival was 98% when bleeding had lasted under 8 weeks before diagnosis and 69% when it had lasted over 16 weeks. But catching a cancer before symptoms did not improve survival in that study. A larger study of more than 1,600 women and a 2020 meta-analysis of nearly 3,000 found that symptom-free cancers were sometimes caught earlier, with no better survival. In UKCTOCS, ultrasound missed about 1 in 4 endometrial cancers or precancers diagnosed within the next year in women without bleeding, even with a 5 mm cutoff. No universal thickness cutoff exists; the 2018 ACOG opinion says transvaginal ultrasound is not an appropriate screening tool for endometrial cancer in postmenopausal women without bleeding.
Race complicates this further. Black women are less likely to be diagnosed at an early stage, are disproportionately affected by aggressive subtypes that can occur with a thin lining, and are more likely to have fibroids that make the endometrium harder to assess. A thin lining can falsely reassure even those who bleed, and no data show it rules out cancer in Black women without symptoms. Women on Medicaid or without private insurance also face worse outcomes. Beyond surgery, screening can bring anxiety, pain, cost, missed work and false reassurance. Gunter's bottom line: if annual screening ultrasounds saved lives, they would be in the guidelines, and prompt evaluation of symptoms, especially postmenopausal bleeding, remains the priority.
Citazioni salienti
If there is one other thing I would change in this country and make mandatory, I would have every single woman on the planet get a pelvic ultrasound.— Dr. Thais Aliabadi, on the Mel Robbins podcast
If annual pelvic ultrasound saved lives, he would insist his own mother get one, but he doesn't recommend it for women without symptoms.— Dr. Mathew Leonardi, paraphrased by Dr. Jen Gunter